drugset / Trial / NCT03304899

Fibrinogen Concentrate in Isolated Traumatic Brain Injury

NCT03304899

Phase 1/2 Unknown 50 enrolled Leila Dehghani
RandomizedParallel-groupDouble-blindPrevention

Summary

Fibrinogen is a unique precursor of fibrin and cannot be compensated for by other coagulation factors. If plasma fibrinogen concentrations are insufficient, hemostatic clots cannot be formed with the appropriate firmness. In severe traumatic brain injury(TBI) patients, plasma fibrinogen concentrations decrease earlier and more frequently than other coagulation factors,predicting massive bleeding and death. The purpose of this study is to try early injection of fibrinogen concentrate in severe isolated traumatic brain injury and investigation the effect of it on post bleeding and complications.

Timeline

Start
2018-10-23
Primary completion
2019-12-21
Completion
2020-01-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic Intravenous